Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 19,671	$ 44,776
Short-term investments	138,645	132,010
Accounts receivable, net of allowance for credit losses of $626 at March 31, 2026 and December 31, 2025	35,527	29,343
Prepaid expenses and other current assets	17,987	14,075
Total current assets	211,830	220,204
Long-term investments	96,582	103,365
Property and equipment, net	9,829	8,587
Operating lease right-of-use assets	14,407	17,488
Restricted cash, non-current	4,702	4,709
Other non-current assets	6,675	5,099
Total assets	344,025	359,452
Current liabilities
Accounts payable	5,750	3,169
Accrued expenses and other current liabilities	25,886	33,279
Operating lease liabilities, current	6,382	5,922
Total current liabilities	38,018	42,370
Operating lease liabilities, non-current	19,967	16,132
Other non-current liabilities	322	303
Total liabilities	58,307	58,805
Commitments and contingencies (Note 7)
Stockholders’ equity
Preferred stock, $0.001 par value; 50,000,000 shares authorized as of March 31, 2026 and December 31, 2025; no shares issued and outstanding as of March 31, 2026 and December 31, 2025
Common stock, $0.001 par value; 250,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 86,105,290 and 85,280,597 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	86	85
Additional paid-in capital	1,401,447	1,388,737
Accumulated other comprehensive loss	(685)	(425)
Accumulated deficit	(1,115,130)	(1,087,750)
Total stockholders’ equity	285,718	300,647
Total liabilities and stockholders’ equity	$ 344,025	$ 359,452